Read More

Psyched: Canada’s Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More

Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms.

IGXT

Read More

MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update

Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. (OTCQB: RVVTF) is undertaking research and development activities for its proprietary transdermal microneedle patch to deliver MDMA toward IND-enabling studies, supported by an exclusive supply deal with PharmaAla Biotech Holdings Inc.

PHRRF